Cargando…

The roles of CYP2C19 and CYP3A4 in the in vitro metabolism of β‐eudesmol in human liver: Reaction phenotyping and enzyme kinetics

β‐eudesmol is a major bioactive component of Atractylodes lancea (AL). AL has been developed as the capsule formulation of standardized AL extract for treating cholangiocarcinoma (CCA). However, the complex constituents of herbal products increase the risk of adverse drug interactions. β‐eudesmol ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muhamad, Nadda, Na‐Bangchang, Kesara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614204/ https://www.ncbi.nlm.nih.gov/pubmed/37902256 http://dx.doi.org/10.1002/prp2.1149

Ejemplares similares

Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice
por: Muhamad, Nadda, et al.
Publicado: (2022)

Modulatory Effects of Atractylodin and β-Eudesmol on Human Cytochrome P450 Enzymes: Potential Drug-Drug Interactions
por: Thiengsusuk, Artitaya, et al.
Publicado: (2023)

Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
por: Srijiwangsa, Pimradasiri, et al.
Publicado: (2018)

The Proteomics and Metabolomics Analysis for Screening the Molecular Targets of Action of β-Eudesmol in Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2021)

β-Eudesmol induces the expression of apoptosis pathway proteins in cholangiocarcinoma cell lines
por: Narahara, Chisato, et al.
Publicado: (2020)

Atractylodin and β-eudesmol from Atractylodes lancea (Thunb.) DC. Inhibit Cholangiocarcinoma Cell Proliferation by Downregulating the Notch Signaling Pathway
por: Vanaroj, Peeranate, et al.
Publicado: (2023)

Effects of β-eudesmol and atractylodin on target genes and hormone related to cardiotoxicity, hepatotoxicity, and endocrine disruption in developing zebrafish embryos
por: Tshering, Gyem, et al.
Publicado: (2022)

Proteomics Analysis for Identification of Potential Cell Signaling Pathways and Protein Targets of Actions of Atractylodin and β-Eudesmol Against Cholangiocarcinoma
por: Kotawong, Kanawut, et al.
Publicado: (2020)

In vitro metabolism, reaction phenotyping, enzyme kinetics, CYP inhibition and induction potential of ataluren
por: Kong, Ronald, et al.
Publicado: (2020)

β-Eudesmol Inhibits the Migration of Cholangiocarcinoma Cells by Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT and p38MAPK Modulation
por: Acharya, Bishwanath, et al.
Publicado: (2022)

Metabolite Profiling in Anticancer Drug Development: A Systematic Review
por: Muhamad, Nadda, et al.
Publicado: (2020)

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
por: Muhamad, Nadda, et al.
Publicado: (2018)

The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma
por: Muhamad, Nadda, et al.
Publicado: (2020)

Bioassay for total serum bioactivity of Atractylodes lancea
por: Na-Bangchang, Kesara, et al.
Publicado: (2023)

In Vitro Human Metabolism and Inhibition Potency of Verbascoside for CYP Enzymes
por: Reid, Anna-Mari, et al.
Publicado: (2019)

Kinetic Characteristics of Curcumin and Germacrone in Rat and Human Liver Microsomes: Involvement of CYP Enzymes
por: Su, Shaofeng, et al.
Publicado: (2022)

Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling
por: Juvonen, Risto O., et al.
Publicado: (2021)

Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2C11 Enzymes in Rat Liver Microsomes: In Vitro Inhibitory Effect of Salicylic Acid on CYP2C11 Enzyme
por: Salhab, Hassan, et al.
Publicado: (2019)

Phase I clinical trial to evaluate the safety and pharmacokinetics of capsule formulation of the standardized extract of Atractylodes lancea
por: Na-Bangchang, Kesara, et al.
Publicado: (2021)

CYP450 Enzyme-Mediated Metabolism of TCAS and Its Inhibitory and Induced Effects on Metabolized Enzymes in Vitro
por: Shen, Guolin, et al.
Publicado: (2015)

Metabolism of ropinirole is mediated by several canine CYP enzymes
por: Tervahauta, Tuomas, et al.
Publicado: (2023)

Combination Analysis in Genetic Polymorphisms of Drug-Metabolizing Enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A5 in the Japanese Population
por: Ota, Tomoko, et al.
Publicado: (2015)

Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism
por: Dias, Vera, et al.
Publicado: (2011)

Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010
por: Muhamad, Poonuch, et al.
Publicado: (2011)

Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border
por: Phompradit, Papichaya, et al.
Publicado: (2014)

Evaluation of heritability of β-eudesmol/hinesol content ratio in Atractylodes lancea De Candolle
por: Tsusaka, Takahiro, et al.
Publicado: (2020)

In vitro modulatory effects of Terminalia arjuna, arjunic acid, arjunetin and arjungenin on CYP3A4, CYP2D6 and CYP2C9 enzyme activity in human liver microsomes
por: Varghese, Alice, et al.
Publicado: (2015)

Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
por: Na-Bangchang, Kesara, et al.
Publicado: (2013)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
por: Bojić, Mirza, et al.
Publicado: (2019)

Effects of Avitinib on CYP450 Enzyme Activity in vitro and in vivo in Rats
por: Shi, Yong, et al.
Publicado: (2021)

CYP2A13 Acts as the Main Metabolic CYP450s Enzyme for Activating Leonurine in Human Bronchial Epithelial Cells
por: Xu, Ting, et al.
Publicado: (2020)

β-Eudesmol, an oxygenized sesquiterpene, stimulates appetite via TRPA1 and the autonomic nervous system
por: Ohara, Kazuaki, et al.
Publicado: (2017)

Nanostructures of diamond, graphene oxide and graphite inhibit CYP1A2, CYP2D6 and CYP3A4 enzymes and downregulate their genes in liver cells
por: Strojny, Barbara, et al.
Publicado: (2018)

Validation of an HPLC Method for the Simultaneous Quantification of Metabolic Reaction Products Catalysed by CYP2E1 Enzyme Activity: Inhibitory Effect of Cytochrome P450 Enzyme CYP2E1 by Salicylic Acid in Rat Liver Microsomes
por: Salhab, Hassan, et al.
Publicado: (2020)

The impact of CYP2D6*41 on CYP2D6 enzyme activity using phenotyping methods in urine, plasma, and saliva
por: Jin, Ye, et al.
Publicado: (2022)

Effect of GLPG1205, a GPR84 Modulator, on CYP2C9, CYP2C19, and CYP1A2 Enzymes: In Vitro and Phase 1 Studies
por: Desrivot, Julie, et al.
Publicado: (2021)

Bioactive constituents isolated from Atractylodes lancea (Thunb.) DC. rhizome exhibit synergistic effect against cholangiocarcinoma cell
por: Martviset, Pongsakorn, et al.
Publicado: (2018)

Antimalarial Activity of Piperine
por: Thiengsusuk, Artitaya, et al.
Publicado: (2018)

Cytotoxicity, Cell Cycle Arrest, and Apoptosis Induction Activity of Ethyl-p-methoxycinnamate in Cholangiocarcinoma Cell
por: Muhamad, Phunuch, et al.
Publicado: (2020)

Inhibition and induction of CYP enzymes in humans: an update
por: Hakkola, Jukka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v113tf07c2r4fncipitavsp4if